Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.80
-0.04 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
7.65
-0.15 (-1.92%)
After-hours: Dec 5, 2025, 6:00 PM EST

Kyverna Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
34.1696.6234.6537.7476.07
Short-Term Investments
136.97189.3622.913.59-
Cash & Short-Term Investments
171.14285.9857.5451.3276.07
Cash Growth
-46.78%396.98%12.12%-32.53%-
Prepaid Expenses
3.794.623.121.931.02
Total Current Assets
174.93290.660.6653.2577.09
Property, Plant & Equipment
6.3210.6610.6112.447.81
Long-Term Deferred Charges
--2.5--
Other Long-Term Assets
5.913.391.421.230.59
Total Assets
187.16304.6575.266.9285.49
Accounts Payable
3.024.624.361.450.77
Accrued Expenses
27.1711.139.067.667.77
Current Portion of Leases
3.693.942.922.280.81
Current Unearned Revenue
----6
Other Current Liabilities
-14.063.520.570.58
Total Current Liabilities
33.8733.7619.8611.9515.93
Long-Term Leases
1.344.36.168.294.74
Long-Term Unearned Revenue
----1.03
Other Long-Term Liabilities
---0.011.33
Total Liabilities
35.2138.0626.0220.2523.02
Additional Paid-In Capital
538.945304.641.710.53
Retained Earnings
-387.02-263.52-136.04-75.68-46.78
Comprehensive Income & Other
0.030.110-0.03-
Total Common Equity
151.95266.59-131.4-74-46.25
Shareholders' Equity
151.95266.5949.1846.6862.47
Total Liabilities & Equity
187.16304.6575.266.9285.49
Total Debt
5.028.249.0810.565.56
Net Cash (Debt)
166.11277.7448.4640.7670.51
Net Cash Growth
-46.84%473.08%18.91%-42.20%-
Net Cash Per Share
3.847.2571.9589.48265.19
Filing Date Shares Outstanding
43.843.2143.120.550.27
Total Common Shares Outstanding
43.7943.211.250.550.27
Working Capital
141.05256.8540.8141.361.16
Book Value Per Share
3.476.17-105.11-133.91-173.96
Tangible Book Value
151.95266.59-131.4-74-46.25
Tangible Book Value Per Share
3.476.17-105.11-133.91-173.96
Machinery
4.446.24.173.743.35
Leasehold Improvements
0.940.820.650.460.08
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q